AnaptysBio Inc reports results for the quarter ended in June - Earnings Summary

AnaptysBio

05/08/2024 22:02

* AnaptysBio Inc  ANAB.OQ  reported a quarterly adjusted
loss of
$1.71​​ per share for the quarter ended in June, lower than the
same quarter last year, when the company reported EPS of
$-1.50.  The mean expectation of eleven analysts for the quarter
was for a loss of 89 cents per share. Wall Street expected
results to range from $-1.73 to 11 cents per share.
    * Revenue rose 217.1% to $10.97 million from a year ago;
analysts
expected $24.30 million. 
    * AnaptysBio Inc's reported EPS for the quarter was a loss
of
$1.71​.
    * The company reported a quarterly loss of $46.66 million.
    * AnaptysBio Inc shares had risen by 30.7% this quarter and
gained 52.9% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 44.2%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 9 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for AnaptysBio Inc is
$48.50 
This summary was machine generated from LSEG data August 5 at
09:01 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -0.89          -1.71          Missed
 Mar. 31 2024      -1.57          -1.64          Missed
 Dec. 31 2023      -1.60          -1.59          Beat
 Sep. 30 2023      -1.79          -1.41          Beat